ArticleIDCases2026
Subcutaneous emphysema as a complication of measles: A case series of nine pediatric patients from Ethiopia.
Article in IDCases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Subcutaneous emphysema is an uncommon complication of measles with potentially serious consequences. This case series describes nine pediatric patients who developed subcutaneous emphysema during a measles outbreak at Bachuma Primary Hospital in rural Ethiopia between October and December 2023. Among 589 children admitted with complicated measles, nine developed subcutaneous emphysema, corresponding to an incidence of 1.52%, at the higher end of previously reported outbreak ranges. All patients were unvaccinated, with a median age of 24 months. Five children had acute malnutrition, including three with severe acute malnutrition and two with moderate acute malnutrition, and eight had clinical signs of micronutrient deficiency. Subcutaneous emphysema manifested a median of 4 days after rash onset, often after initiation of humidified nasal oxygen at 2-6 L/min. Management included supportive care, vitamin A, antibiotics when clinically indicated, nutritional rehabilitation, close monitoring, and emergency decompression when pneumothorax was suspected. Five patients were transferred to a regional hospital; four recovered and one died within 48 h after transfer from hypoxemic respiratory failure. This series highlights the importance of vigilance for air-leak complications in children with severe measles pneumonia, malnutrition, and oxygen requirement in resource-limited outbreak settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.